About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in San Antonio | 3,569 Studies Near You

Clinical TrialsSan Antonio

Clinical Trials in San Antonio

Discover 3,569 clinical trials near San Antonio, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2481-2500 of 3,569 trials

CompletedA Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne VulgarisThe objective of this study is to assess the long-term safety of Olumacostat Glasaretil gel, 5.0% in patients with acne vulgarisNCT03127956·Guntersville, Alabama and 93 others

Find Trials by Condition in San Antonio

Breast Cancerin San Antonio Lung Cancerin San Antonio Prostate Cancerin San Antonio Colorectal Cancerin San Antonio Melanomain San Antonio Leukemiain San Antonio Lymphomain San Antonio Pancreatic Cancerin San Antonio Ovarian Cancerin San Antonio Brain Cancerin San Antonio

Data from ClinicalTrials.govTerms

TerminatedA Study of Ustekinumab in Participants With Active Systemic Lupus ErythematosusThe purpose of this study is to evaluate the efficacy of ustekinumab in participants with active systemic lupus erythematosus (SLE) who have not adequately responded to one or…NCT03517722·Anniston, Alabama and 203 others

TerminatedHORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005The purpose of this clinical study was to evaluate the safety and efficacy of two doses of GT005 administered as a single subretinal injection in subjects with geographic atrophy…NCT04566445·Phoenix, Arizona and 61 others

CompletedArsenic Trioxide in Treating Men With Germ Cell CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00036842·Mobile, Alabama and 93 others

UnknownStudy of eFT226 in Subjects With Selected Advanced Solid Tumor MalignanciesThis clinical trial is a Phase 1-2, open-label, sequential-group, dose-escalation and cohort-expansion study evaluating the safety, pharmacokinetics (PK), pharmacodynamics, and…NCT04092673·Los Angeles, California and 13 others

CompletedOCS Liver PROTECT Continuation Post-Approval StudyPost-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT Trial.NCT05096741·La Jolla, California and 16 others

CompletedEPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac ArteriesThe ORION study is being conducted to determine whether the Epic™ Nitinol Stent for primary stenting of iliac atherosclerotic lesions shows acceptable performance at 9 months.NCT00896337·Tucson, Arizona and 27 others

CompletedGISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation RecurrenceStudy purpose The purpose of the study is to show that the addition of valsartan on top of established therapies can reduce the recurrence of atrial fibrillation in patients with…NCT00376272·Cortona, AR and 113 others

Active not recruitingPhase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)A Phase 3, randomized, blinded study comparing pelabresib (CPI-0610) and ruxolitinib with placebo and ruxolitinib in myelofibrosis (MF) patients that have not been previously…NCT04603495·Birmingham, Alabama and 155 others

RecruitingComparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana LinfomiProspective, multicenter, open label, phase III randomized clinical trial in previously untreated Follicular Lymphoma in early stage.NCT05929222·Sassuolo, Modena (MO) and 48 others

Active not recruitingQuantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's DiseaseThis study aims to assess the levels of phosphorylated alpha-synuclein (P-SYN) in patients with Parkinson's disease and REM Behavior Disorder using a minimally invasive skin punch…NCT06621602·Scottsdale, Arizona and 17 others

CompletedEfficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic DisorderThe purpose of this study is to assess and compare the effects of 3 dose strengths of TBS-2 intranasal testosterone gel to placebo on the occurrence of orgasm.NCT01607658·Birmingham, Alabama and 52 others

CompletedStress-Busting Program and QoL, Bio-markers of Immunity/Stress and Cellular AgingThe purpose of this study is to explore the differences in quality of life , inflammation, stress, telomere length, and mucosal immune function of Hispanic and non-Hispanic…NCT02844478·San Antonio, Texas

CompletedStudy on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous SystemPrimary central nervous system lymphomas are rare aggressive malignancies, usually treated in two steps: an induction phase (where a combination of chemotherapy is given) followed…NCT03495960·Aarhus and 33 others

RecruitingA Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in…NCT06312176·Chandler, Arizona and 258 others

Active not recruitingA Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)This Phase II study aims to evaluate the efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg QD doses + lutetium (177Lu)…NCT07047118·Duarte, California and 43 others

RecruitingLifestyles Implemented-Survivorship Care Plan In Lymphoma SurvivorsThis is a prospective randomized open-label, multicenter, 2-arm study to assess the role of healthy LifeStyle implemented Survivorship Care Plan (LS-SCP) in modifying the Quality…NCT05934084·Ancona, Ancona and 39 others

UnknownInformational App Development for mHealth for Patient Self-Management of Opioid Use DisorderThis study will evaluate the feasibility of an app that provides drug information to people in recovery from opioid use disorder.NCT05859035·San Antonio, Texas

Active not recruitingA Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerThe main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy, and how well imlunestrant with abemaciclib work compared to…NCT04975308·Chandler, Arizona and 242 others

CompletedSPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated PainThe purpose of this study is to evaluate the long-term efficacy and safety of relugolix 40 milligram (mg) once daily co-administered with low-dose estradiol (E2) and norethindrone…NCT03654274·Andalusia, Alabama and 168 others

PreviousPage 125 of 179Next

Diabetes

in San Antonio

Heart Diseasein San Antonio